Novel research into the anti-aging and anti-inflammatory gene, Sirtuin 1 (SIRT1), has shown decreased levels in patients with MetS, T2DM and psoriasis, further supporting the pro-inflammatory alterations that underly psoriasis (27, 28). This evidence concerns the gene SIRT1 and metabolic syndrome.